Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Intervention, Randomized, Mulitcenter, Placebo-Controlled, 4-Period Crossover, Multi-Attack Study to Evaluate Efficacy & Safety of ComboProduct Containing Sumatriptan and Naproxen Sodium for Acute Treatment of Migraine in Adolescents

NCT01016678 is registered in ClinicalTrials.gov with Premiere Research Institute as lead sponsor.

NCT NCT01016678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01016678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Intervention, Randomized, Mulitcenter, Placebo-Controlled, 4-Period Crossover, Multi-Attack Study to Evaluate Efficacy & Safety of ComboProduct Containing Sumatriptan and Naproxen Sodium for Acute Treatment of Migraine in Adolescents
Lead sponsor
Premiere Research Institute
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2010
Completion date
July 31, 2014
Enrollment
104 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

migraine